Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape

Myelodysplastic neoplasms (MDS) are a heterogenous clonal disorder of hemopoietic stem cells characterized by cytomorphologic dysplasia, ineffective hematopoiesis, peripheral cytopenias and risk of progression to acute myeloid leukemia (AML). Our understanding of this disease has continued to evolve...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Daniel Karel, Claire Valburg, Navitha Woddor, Victor E. Nava, Anita Aggarwal
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-04-01
Edice:	Current Oncology
Témata:	myelodysplastic neoplasm myelodysplastic syndrome MDS precision medicine targeted therapy
On-line přístup:	https://www.mdpi.com/1718-7729/31/4/148
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!